BRUCE ERIC J 4
4 · KING PHARMACEUTICALS INC · Filed Jan 5, 2010
Insider Transaction Report
Form 4
BRUCE ERIC J
President, Animal Health
Transactions
- Exercise/Conversion
Long-Term Performance Unit
2009-12-31−21,120→ 0 totalExp: 2009-12-31→ Common Stock (21,120 underlying) - Exercise/Conversion
Common Stock
2009-12-31+21,120→ 176,195 total
Footnotes (1)
- [F1]Each Long-Term Performance Unit represented a contingent right to receive a share of King Pharmaceuticals, Inc. common stock if the reporting person remained employed by King Pharmaceuticals, Inc. during the two-year vesting period that ended on December 31, 2009.